M&A Deal Summary

JLL Partners and DSM-Firmenich Acquire DPx Holdings BV

On March 11, 2014, private equity firm JLL Partners and DSM-Firmenich acquired life science company DPx Holdings BV for 2.7B USD

Acquisition Highlights
  • This is JLL Partners’ 5th and DSM-Firmenich’s 6th transaction in the Life Science sector.
  • This is JLL Partners’ and DSM-Firmenich’s largest (disclosed) transaction.
  • This is JLL Partners’ 22nd and DSM-Firmenich’s 11th transaction in the United States.
  • This is JLL Partners’ 2nd and DSM-Firmenich’s 2nd transaction in Massachusetts.

M&A Deal Summary

Date 2014-03-11
Target DPx Holdings BV
Sector Life Science
Buyer(s) JLL Partners
DSM-Firmenich
Deal Type Buyout (LBO, MBO, MBI)
Deal Value 2.7B USD

Target

DPx Holdings BV

Framingham, Massachusetts, United States
DPx Holdings BV is a provider of development and manufacturing services, pharmaceutical products and technologies and select chemical products for other industries. DPx Holdings was founded in 2014 and is based in Framingham, Massachusetts.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

JLL Partners

New York, New York, United States

Investor Investor Investor Investor


Category Private Equity Firm
Founded 1988
PE ASSETS 5.8B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

JLL Partners, Inc. is a private equity investment firm that invests alongside management in middle-market companies. JLL prefers control investments in sectors such as healthcare services, medical products, food and consumer products, chemicals, broadcasting, transportation, automotive, industrial manufacturing, and distribution. In addition to traditional buyout transaction, JLL also seeks distressed/turnaround situations. JLL Partners was formed in 1988 and is based in New York City.


DEAL STATS #
Overall 23 of 40
Sector (Life Science) 5 of 7
Type (Buyout (LBO, MBO, MBI)) 6 of 9
State (Massachusetts) 2 of 3
Country (United States) 22 of 38
Year (2014) 1 of 1
Size (of disclosed) 1 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-11-19 Patheon BV

Durham, North Carolina, United States

Patheon BV is a global provider of pharmaceutical development and manufacturing services. With approximately 9,000 professionals worldwide, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help clients of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. A Healthier World. Delivered.

Buy $2.6B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-12 CCBR-SYNARC

Newark, California, United States

CCBR-SYNARC, Inc. is a medical image-analysis, subject-recruitment, and biochemical marker services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development.

Sell -
Buyer

DSM-Firmenich

Kaiseraugst, Switzerland

Category Company
Founded 1902
Sector Chemicals
Employees27,926
Revenue 10.6B EUR (2023)
DESCRIPTION

DSM-Firmenich specializes in development, manufacture and marketing of performance materials, nutritional and pharmaceutical ingredients and industrial chemicals. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. DSM-Firmenich founded in 1902 and is based in Kaiseraugst, Switzerland.


DEAL STATS #
Overall 22 of 28
Sector (Life Science) 6 of 9
Type (Buyout (LBO, MBO, MBI)) 1 of 1
State (Massachusetts) 2 of 2
Country (United States) 11 of 11
Year (2014) 2 of 2
Size (of disclosed) 1 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-21 Roche Vitamins and Fine Chemicals

Kaiseraugst, Switzerland

Roche Vitamins and Fine Chemicals is a producer of vitamins, carotenoids, nutritional lipids, enzymes and other healthy ingredients for human and animal nutrition.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-03-02 Euroresins Benelux bv

Budel,, Netherlands

Euroresins is a distributor of products to the composite resins industry with activities in nine countries in Europe.

Sell -